![Lars Abrahmsén](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Abrahmsén
Directeur Technique/Scientifique/R&D chez
Akinion Pharmaceuticals AB
Profil
Lars Abrahmsén is currently working as CSO & VP-Preclinical Development at Akinion Pharmaceuticals AB and KDev Oncology AB. He previously worked as Principal at Genentech, Inc., Senior Project Team Leader at Pharmacia & Upjohn, Inc., Chief Scientific Officer at Affibody AB, Senior Project Team Leader at Biovitrum AB, Senior Vice President-Protein Therapeutics at Algeta ASA, CSO & VP-Preclinical Development at Axelar AB, and Principal at Kabi Pharmacia.
He completed his graduate and doctorate degrees from the Royal Institute of Technology.
Postes actifs de Lars Abrahmsén
| Sociétés | Poste | Début |
|---|---|---|
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Directeur Technique/Scientifique/R&D | - |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Lars Abrahmsén
| Sociétés | Poste | Fin |
|---|---|---|
| APREA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 02/08/2022 |
| ALGETA ASA | Corporate Officer/Principal | 01/01/2013 |
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Directeur Technique/Scientifique/R&D | - |
Formation de Lars Abrahmsén
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Kabi Pharmacia | |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
